Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05090293 · ClinicalTrials.gov registry record · NA
Optimizing Weight Loss Outcomes Through Body Image Enhancement
A NA study of Overweight and Obesity, sponsored by Texas Tech University.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 2
- Study locations
NCT05090293: Completed NA study of Overweight and Obesity, sponsored by Texas Tech University.
NCT05090293 is a NA study of Overweight and Obesity that has completed, run by Texas Tech University. The registered enrollment target is 58 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05090293, a NA study of Overweight and Obesity, has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will examine if a standard group-delivered cognitive behavioral lifestyle intervention for weight loss can be improved via the incorporation of a novel body image intervention designed to address body image and improve weight loss outcomes in a sample of women with overweight/obesity.
Primary Outcome
Changes in weight loss
Conditions Studied
Interventions
- BEHAVIORAL Experimental: Lifestyle Intervention with Body Image Treatment (LIBI)
- BEHAVIORAL Lifestyle Intervention (LI)
Study Locations (2)
Texas
- Texas Tech University - Department of Nutritional Sciences - Lubbock
- Nutrition & Metabolic Health Initiative - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2021-09-13 |
| Est. Completion | 2022-05-08 |
| Phase | NA |
What the finished NCT05090293 record still lists
NCT05090293 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Experimental: Lifestyle Intervention with Body Image Treatment (LIBI) is the first listed.
NCT05090293 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05090293 about?
NCT05090293 is a clinical study titled "Optimizing Weight Loss Outcomes Through Body Image Enhancement". The study will examine if a standard group-delivered cognitive behavioral lifestyle intervention for weight loss can be improved via the incorporation of a novel body image intervention designed to address body image and improve weight loss outcomes in a sample of women with overweight/obesity.
What is the current status of trial NCT05090293?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2021-09-13. Estimated completion is 2022-05-08.
What conditions does trial NCT05090293 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT05090293?
The interventions under investigation include: Experimental: Lifestyle Intervention with Body Image Treatment (LIBI) (BEHAVIORAL), Lifestyle Intervention (LI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05090293?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05090293 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05090293's enrollment target sits among peer trials
58 83rd of 115 higher than 32 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI